EUA
Labcorp VirSeq SARS-CoV-2 NGS Test
FDA Emergency Use Authorization · Laboratory Corporation of America (Labcorp) · Jun 10, 2022
Key facts
| Product | Labcorp VirSeq SARS-CoV-2 NGS Test |
|---|---|
| Company | Laboratory Corporation of America (Labcorp) |
| Product type | Next Generation Sequencing (NGS), PANGO lineage |
| Date | Jun 10, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: